New Zealand markets open in 3 hours 50 minutes

9 Meters Biopharma, Inc. (NMTRQ)

OTC Markets EXMKT - OTC Markets EXMKT Delayed price. Currency in USD
Add to watchlist
0.00010.0000 (0.00%)
At close: 11:04AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.45k
Enterprise value -1.77M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)4.58
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.59

Trading information

Stock price history

Beta (5Y monthly) 47.94
52-week change 3-99.99%
S&P500 52-week change 322.55%
52-week high 30.7138
52-week low 30.0000
50-day moving average 30.0001
200-day moving average 30.0018

Share statistics

Avg vol (3-month) 32.06k
Avg vol (10-day) 312.67k
Shares outstanding 514.46M
Implied shares outstanding 614.46M
Float 814.22M
% held by insiders 11.71%
% held by institutions 10.01%
Shares short (14 Jul 2023) 4580.63k
Short ratio (14 Jul 2023) 414.12
Short % of float (14 Jul 2023) 44.08%
Short % of shares outstanding (14 Jul 2023) 44.02%
Shares short (prior month 15 Jun 2023) 4578.95k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 318 Oct 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Mar 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-111.78%
Return on equity (ttm)-375.64%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -43.43M
Net income avi to common (ttm)-46.28M
Diluted EPS (ttm)-3.5200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)6.94M
Total cash per share (mrq)0.48
Total debt (mrq)5.17M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.59
Book value per share (mrq)-0.44

Cash flow statement

Operating cash flow (ttm)-37.24M
Levered free cash flow (ttm)-21.02M